Comprehensive review and trial results of upcoming antidepressant Ruoxinlin (ansofaxine) mdpi.com Submitted by That-Group-7347 t3_11nhpwn on March 10, 2023 at 7:00 AM in science 10 comments 8
That-Group-7347 OP t1_jbnaeag wrote on March 10, 2023 at 7:01 AM It is referenced in this article as Toludesvenlafaxine. This was just published. It has been available in China since last November and is expected to be available in the U.S. in 2024. It will be the first full SNDRI available on the market. Permalink 2
Viewing a single comment thread. View all comments